Rheumatology

A new study suggests that menopausal hormone therapy (MHT) may increase the risk of systemic lupus erythematosus and systemic sclerosis.

Secukinumab shows high drug survival and sustained effectiveness in psoriatic arthritis patients, with better outcomes in mixed peripheral and axial involvement.

A study of over 1,700 psoriatic arthritis patients across nine European countries reveals that tumor necrosis factor inhibitors (TNFi) work differently depending on the affected joint.

A new study has found a causal link between rheumatoid arthritis and an increased risk of prostate cancer, highlighting the role of chronic inflammation in cancer development.

A new study has found strong genetic evidence that air pollution can significantly increase the risk of autoimmune diseases, including rheumatoid arthritis and lupus.

A new study shows that biologic treatments significantly reduce inflammation and improve jaw function in children with juvenile idiopathic arthritis (JIA) affecting the temporomandibular joint (TMJ).

A study using the KOBIO registry reveals a 39 per 1,000 person-year infection rate in ankylosing spondylitis (AS) patients receiving biologics. Respiratory tract infections and herpes zoster were the most common, with age, diabetes, and kidney disease among key risk factors.

A groundbreaking analysis of the ESTHER trial reveals that resolution of MRI-detected inflammation in the sacroiliac joints is strongly linked to improved clinical outcomes in patients with axial spondyloarthritis undergoing long-term anti-TNF therapy.